ArticleJournal of biomedical research & environmental sciences2025
Inflammation Markers and HCC Aggressiveness.
Article in Journal of biomedical research & environmental sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Background: Inflammation is thought to be important in the development and progression of Hepatocellular Carcinoma (HCC), but which inflammatory indices are more useful in clinical practice is not clear. Aims: Several inflammatory indices were examined with respect to Maximum Tumor Diameter (MTD), Portal Vein Thrombosis by Tumor (PVT) and survival. Results: Serum C-Reactive Protein (CRP) and Platelet Lymphocyte Ratio (PLR) each significantly increased with increasing MTD as did percent patients with higher Glasgow index; whereas albumin levels and HALP (Hemoglobin, Albumin, Lymphocytes and Platelets) score decreased, as expected. Lower (abnormal) albumin was associated with higher alpha-fetoprotein and percentage PVT patients. Cox proportional hazard models for death showed a significant protective effect for albumin, whereas CRP and the Glasgow score had significant Hazard Ratios (HR) for death, but neither PLR nor the HALP score had significant HRs. Kaplan-Meier analysis showed reduced survival at each MTD for patients with low versus high albumin levels. All parameters were significantly different for presence versus absence of PVT, but only albumin and CRP had significance in Cox proportional hazard models for death in patients with PVT and only albumin for patients with high alpha-fetoprotein. Conclusion: Each inflammation parameter worsened with increase in MTD, but only albumin and CRP (and the Glasgow index) were significant for survival in the total cohort. Only serum albumin had significance for survival in patients with PVT or high alpha-fetoprotein.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.